ARTICLE | Financial News
Esperion files for IPO
February 24, 2000 8:00 AM UTC
Esperion (Ann Arbor, Mich.), which is developing HDL-raising therapeutics to treat cardiovascular and metabolic diseases, filed to raise up to $138 million in an IPO. The deal will be underwritten by ...